logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Share:
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for cytx
Nick zheng
23 Sep 14 09:16:24
$CYTX is proving its fat cells are useless. There is no short path to prosperity. Sell.
Equities.com
22 Sep 14 14:47:27
Cytori Therapeutics Inc (CYTX) Drops 13.04% on September 22 $cytx http://t.co/kMC11GfdFT
Day Trade Alerts
22 Sep 14 10:22:20
via #AlertTrade SHORT Seller Alert $CYTX - CYTORI THERAPEUTICS #ShortSeller #Stocks http://t.co/VS8RO1bzXJ
Daily Contracts
22 Sep 14 07:38:00
Real-Time feed of company contracts, original agreements and executive updates from Cytori Therapeutics Inc $CYTX http://t.co/gqwpW5tHRQ
Alex Galan
22 Sep 14 07:26:56
RT @Briefingcom: $CYTX: Cytori Therapeutics consolidates and restructures its operations, provides business update; after the... http://t.c…
Kevbeau68
22 Sep 14 07:18:30
RT @Briefingcom: $CYTX: Cytori Therapeutics consolidates and restructures its operations, provides business update; after the... http://t.c…
Briefing.com
22 Sep 14 07:16:42
$CYTX: Cytori Therapeutics consolidates and restructures its operations, provides business update; after the... http://t.co/nbRG1hdiOo
Cytori IR
22 Sep 14 06:41:13
$CYTX Consolidates and Restructures Its Operations, Provides Business Update: http://t.co/GtXPuKVl4C
Stock Moo
22 Sep 14 05:44:17
$cytx: Cytori Consolidates and Restructures Its Operations, Provides Business Update http://t.co/bJDwSmpArt
Big Money Plays
22 Sep 14 05:38:19
georgie18: $CYTX.... $1.00...Pincher Play....ADX...PPO..pinching..divergence will lead to a http://t.co/jBL6uvYUyU
Chill Till
22 Sep 14 05:15:06
$CYTX Cytori announces restructuring, cost reduction plans. http://t.co/OW4wzei7aG
NathanAaron
22 Sep 14 05:07:29
$cytx cutting unneeded expenses...not sure why they had them in the first place....
BV Healthcare
22 Sep 14 05:04:19
$CYTX Cytori Consolidates and Restructures Its Operations, Provides Business Update.. http://t.co/c2gFDXY3w3
StockNews
22 Sep 14 05:03:32
$CYTX - Cytori Consolidates and Restructures Its Operations, Provides Business Update http://t.co/0coSLffaX5
NASDAQ
22 Sep 14 05:03:17
$CYTX - Cytori Consolidates and Restructures Its Operations, Provides Business Update http://t.co/gmC1nK0j4W
VisualStock Resource
22 Sep 14 05:02:24
$CYTX - Cytori Consolidates and Restructures Its Operations, Provides Business Update http://t.co/kLGiqS2V65
$Stocknewsalerts
22 Sep 14 05:00:48
$CYTX Cytori - Cytori Consolidates and Restructures Its Operations, Provides Business Update From our Stock News Alerts App
Stockchartz
21 Sep 14 03:53:11
georgie18: $CYTX.... $1.00...Pincher Play....ADX...PPO..pinching..divergence will lead to a http://t.co/cLM9QooXC2
Equities.com
19 Sep 14 14:48:12
Cytori Therapeutics Inc (CYTX) Jumps 6.37% on September 19 $cytx http://t.co/6swqRLekAC
StockNews
19 Sep 14 14:00:09
$CYTX - Current Report Filing (8-k) http://t.co/kGkfA8vTxD
4-traders.com
19 Sep 14 14:00:04
Cytori Therapeutics USA : , INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity ... http://t.co/b5zsFeSy4N $CYTX
VisualStock Resource
19 Sep 14 14:00:01
$CYTX - Current Report Filing (8-k) http://t.co/NvYPcGt1e2
NASDAQ
19 Sep 14 13:59:50
$CYTX - Current Report Filing (8-k) http://t.co/yMaJUzxrwA
BV Healthcare
19 Sep 14 13:57:05
$CYTX Cytori Therapeutics, Inc files Form 8-K (Events or Changes Between Quarterly Reports) SEC Filing.. http://t.co/8diZg5L4NI
$Stocknewsalerts
19 Sep 14 13:56:32
$CYTX Cytori - 8-K (Current report filing) SEC Filing From our Stock News Alerts App
$$$ Money $$$
18 Sep 14 20:06:46
$ARQL $ANTH $CYTX $SGYP $GTXI $RPRX bios hitting 52wks low today. Yikes! $SGYP seem like strong candidate for bounce run up.
GAVIN
18 Sep 14 18:16:28
$CYTX the next $DRIO? put on watch for a couple of weeks from now.
MAISA
18 Sep 14 18:11:16
#52WeeksLow today = $CYTX $0.94 = $ECTE $0.97 = $MELA $1.89 = $RPRX $10.09
Equities.com
18 Sep 14 16:33:08
Cytori Therapeutics Inc (CYTX) Drops 7.83% on September 18 $cytx http://t.co/x47L23cKJH
FsCtrades
17 Sep 14 21:08:59
$CYTX this thing has further to go...would not be surprised to see another flush in the near future.
TickerChirp
17 Sep 14 08:14:06
The Top Tweets Relevant to $CYTX on 09/17/2014 http://t.co/RjEIQmr9M3
Daily Contracts
16 Sep 14 09:12:00
Real-Time feed of company contracts, original agreements and executive updates from Cytori Therapeutics Inc $CYTX http://t.co/gqwpW5tHRQ
FilingsAnalysis
16 Sep 14 04:25:04
$CYTX, 13D filed by Olympus Corp http://t.co/3diJ6mj5YO
StockNews
16 Sep 14 03:09:51
$CYTX - Amended Statement of Beneficial Ownership (sc 13d/a) http://t.co/gKkr0Phjsg
VisualStock Resource
16 Sep 14 03:09:46
$CYTX - Amended Statement of Beneficial Ownership (sc 13d/a) http://t.co/grbnyKd4wR
NASDAQ
16 Sep 14 03:09:22
$CYTX - Amended Statement of Beneficial Ownership (sc 13d/a) http://t.co/5Z3lIjvR3C
InsiderTradingWire
16 Sep 14 03:05:10
13D Alert for CYTORI THERAPEUTICS, INC. - $CYTX - #13D #insidertrading - http://t.co/oGSgJVKCf3
$Stocknewsalerts
16 Sep 14 03:03:23
$CYTX Cytori - SC 13D/A (Amended Statement of Beneficial Ownership) SEC Filing From our Stock News Alerts App
				
				
By  +Follow August 1, 2013 8:43AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.